Dermatoses, corticosensitive to the scalp

· Psoriasis

· Seborrheic dermatitis

· Lichenification.

Note: Each dermatosis should be treated with a corticoid of the most appropriate level, knowing that depending on the results one may be led to substitute a product of a stronger or less strong activity on all or part of the Lesions.

This emulsion form is intended for lesions of the hair and scalp regions.

Treatment should be limited to 1 to 2 applications per day.

An increase in the number of daily applications could increase the adverse effects without improving the therapeutic effects

The lotion should be applied in stripe, in small quantities, directly on the leather, hair. Wash hands after application

Some dermatoses make it desirable, a progressive stop. It can be achieved by decreasing the frequency of applications and / or using a less strong corticosteroid or less dosage.
DERMOCORTICOIDE, strong activity

(D. Dermatology)

Dermocorticoids are classified into 4 activity levels according to skin vasoconstriction tests: very strong, strong, moderate, weak activity.

Active on certain inflammatory processes (eg contact hypersensitivity) and the pruritic effect associated with them. Vasoconstrictor: Inhibits cell multiplication

No studies evaluating the effect of betamethasone valerate on the ability to drive or use machines have been performed, and an adverse effect on these activities can not be anticipated from the profile Of the known undesirable effects of betamethasone valerate by the topical route

· Hypersensitivity to one of the constituents of the preparation

· Primitive bacterial, viral, fungal or parasitic infections

· Ulcerated lesions.

· Application on the eyelids (risk of glaucoma).

The prolonged use on the face of corticoids with strong activity exposes the occurrence of a cortico-induced and paradoxically cortico-sensitive dermatitis, with rebound after each stop. A gradual, especially difficult, withdrawal is then necessary.

Precautions, special

Due to the passage of the corticosteroid, in the general circulation, the treatment of large cutaneous surfaces or under occlusion (dressing or layers), prolonged use or high doses may entail the systemic effects of general corticosteroids; Especially in infants and children below age. They consist of a cushingoid syndrome and a slowing of growth. These accidents disappear, upon cessation of treatment. In this situation, topical corticosteroids should be stopped gradually under medical supervision because a sudden arrest may be followed, acute adrenal insufficiency
< Code>
In case of bacterial or mycotic infection of a cortico-sensitive dermatosis, precede the use of the corticosteroid for a specific treatment.

If local intolerance appears, treatment is discontinued and the cause must be sought.

Avoid contact with eyes.

This medicine contains alcohol, ketostearyl and may cause local skin reactions (eg, eczema).
There is very little probable that an acute overdose will occur, however in case of chronic overdose or misuse, signs of hypercorticism may appear.
In this situation, topical corticosteroids should be phased out under medical supervision because of the risk of adrenal insufficiency.

No animal teratogenicity studies have been carried out with locally administered corticosteroids.
Nevertheless, studies on the use of corticosteroids have not revealed a malformative risk higher than that observed in the general population. >
Accordingly, this medicament may be prescribed during pregnancy if needed.

In the case of oral treatment, breast-feeding should be avoided as corticosteroids are excreted in human milk

The transdermal passage and thus the risk of excretion of the corticosteroid in the milk will be localized according to the surface treated, the degree of epidermal alteration and the duration of the treatment.
< Br>

The adverse reactions listed below were observed during the trials. They are classified by class organ and by frequency. Frequencies are defined, very common (≥1 / 10), frequent (≥ 1/100, and